Provention Bio PRVB
$ 24.98
0.0%
Annual report 2022
added 03-29-2023
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Ashleigh Palmer |
Employees in the company |
19 |
Shares |
74.7 M |
Market Cap[1] |
$ 2.37 B |
EBITDA (LTM) |
$ -115 M |
P/E (LTM) |
-4.68 |
P/S (LTM) |
320.36 |
EPS (LTM) |
-1.58 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.